AT
SANA icon

Arlington Trust’s Sana Biotechnology SANA Stock Holding History

Arlington Trust’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,520
Closed -$6.19K – 861
2025
Q4 		$6.19K Hold
1,520
– – ﹤0.01% 361
2025
Q3 		$5.4K Hold
1,520
– – ﹤0.01% 521
2025
Q2 		$4.15K Hold
1,520
– – ﹤0.01% 540
2025
Q1 		$2.55K Buy
+1,520
New +$4.25K ﹤0.01% 579
2024
Q4 		– Sell
-364
Closed -$1.51K – 571
2024
Q3 		$1.51K Hold
364
– – ﹤0.01% 535
2024
Q2 		$1.99K Hold
364
– – ﹤0.01% 508
2024
Q1 		$3.64K Hold
364
– – ﹤0.01% 446
2023
Q4 		$1.49K Buy
+364
New +$1.34K ﹤0.01% 721

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Arlington Trust's SANA Position: Q1 2026 in Review

Arlington Trust sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 1,520 shares — an estimated $6.19K sold.

Arlington Trust first reported a position in SANA in Q4 2023 and held it in 8 quarters. The position peaked at $6.19K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Arlington Trust reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Arlington Trust sold 1,520 Sana Biotechnology shares in Q1 2026, an estimated $6.19K.
  • Arlington Trust first reported a position in Sana Biotechnology in Q4 2023 and held it in 8 quarters.
  • Arlington Trust's Sana Biotechnology position peaked at $6.19K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Arlington Trust's 13F filing for Q1 2026, filed 8 Apr 2026.